mydxlife.comMyDx | Portable Chemical Analyzer | CDX

-- -- -- -- -- -- -- -- -- -- -- -- -- LEARN CONSUMER PRODUCTS CannaDx™ OrganaDx® AquaDx® AeroDx® MyDx One App™ ECO Smart Pen by MyDx MyDx Tablet Edition DATA ANALYTICS Dataset & Algorithms MyDx Reports SaaS MyDx One App MyDx360 MyDx Smart Label Services BIOPHARMACEUTICALS Development and Clinical Validation gAPI Clinical Trial Pipeline MyDx Privacy Pledge to Patients MyDx Global Code of Ethics for Clinical Trials ABOUT MYDX MyDx Technology Mission Team History SHOP CannaDx™ MyDx One App™ ECOSMART PEN™ MyDx360 OrganaDx AquaDx AeroDx MEDIA PRESS / NEWS REVIEWS VIDEOS BLOG SUPPORT Contact Terms of Use Privacy Policy FAQ Warranty Product Registration Our mission is to help people Trust & Verify ® what they put into their mind and body. Watch MyDx Videos MyDx, Inc. ( Ticker :MYDX) is a science and technology company and creator of MyDx® (My Diagnostic), the first multi-use handheld chemical analyzer that will test for pesticides in the food you eat, chemicals in the water you drink, toxins in the air you breathe, and the safety and potency of your cannabis samples. Featured In Track the efficacy of the products you consume. Find a strain profile that works for you. Get our free app. Available on App Store and Google Play Join our email list to get the latest news. I consent to receive promotional emails about MyDx (See Privacy Policy on how we protect and manage your submitted data). Our more immediate mission is to continue to develop smart devices as part of an ecosystem that crowdsources consumer generated preclinical data to drive innovation in the cannabis industry. The cannabis industry’s first hand-held cannabis sensor and analyzer with disposable single use inserts. Learn More Buy Now Dosage Tracker Dosage Scheduler Child Safety Lock Bluetooth Compatible & much more… Learn More Pre-Order Develop branded formulations & secure customer feedback. Learn More Get Started Cannabis Businesss Overview MyDx Business Segments Servicing The Cannabis Industry Consumer Products CannaDx tests the chemical profile of Cannabis and will be joined by other smart devices such as the EcoSmartPen and consumables to help patients find a strain profile that works for them. LEARN MORE Data Analytics Data Analytics will focus on pre-clinical chemical analyses and our patient feedback ecosystem to provide actionable insights such as trend reports and formulations. LEARN MORE Bio-pharmaceuticals Biopharmaceuticals will identify green Active Pharmaceutical Ingredients™ (gAPI™) and corresponding formulations to provide symptom relief alternatives in a clinical setting. LEARN MORE Software as a Service The SaaS segment will provide software services for prescribers, patient groups, cultivators, and regulators, including MyDx360, the Smart Label Generator, and the MyDx One App. LEARN MORE LEARN CONSUMER PRODUCTS CannaDx™ OrganaDx® AquaDx® AeroDx® MyDx One App™ ECO Smart Pen by MyDx MyDx Tablet Edition DATA ANALYTICS Dataset & Algorithms MyDx Reports SAAS MyDx One App MyDx360 MyDx Smart Label Services BIOPHARMACEUTICALS Development and Clinical Validation gAPI Clinical Trial Pipeline MyDx Privacy Pledge to Patients ABOUT US MyDx Technology Team Mission History SHOP CannaDx™ MyDx One App™ EcoSmart Pen MyDx360 OrganaDx AquaDx AeroDx MEDIA Press / News Video Reviews Blog SUPPORT Contact Terms of Use Privacy Policy FAQ Warranty Product Registration CONTACT MyDx, Inc. 4225 Executive Square Suite 600 La Jolla, CA 92037 Email: info@mydxlife.com © Copyright 2020 CDx, Inc., a wholly-owned subsidiary of MyDx, Inc. All Rights Reserved Disclaimer: All statements and expressions are the sole opinion of the Company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as "expects", "will", "anticipates", "estimates", "believes", or by statements indicating certain actions "may", "could", "should" or "might" occur....